Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer

Documenti analoghi

• Interface Engineering to Operate Reversible Protonic Ceramic Electrochemical Cells Below 500 °C (Adv. Energy Mater. 2/2025)
  di: Mingi Choi, et al.
  Pubblicazione: (2025)
• Correction to: Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer
  Pubblicazione: (2024)
• Toll‐Like Receptor Blockage by TIP‐1 and MIP‐2 Treatment Mitigates Inflammation in a Mouse Model of Adult‐Onset Still's Disease or Still's Disease
  di: Mi‐Hyun Ahn, et al.
  Pubblicazione: (2025)
• HBRB-BoW: A Retrained Bag-of-Words Vocabulary for ORB-SLAM via Hierarchical BRB-KMeans
  di: Lee, Minjae, et al.
  Pubblicazione: (2026)
• Prognostic value of initial and longitudinal changes in body composition in metastatic pancreatic cancer
  di: Min Woo Lee, et al.
  Pubblicazione: (2024)